Learn more

ONCOMEDX INC

Overview
  • Total Patents
    45
  • GoodIP Patent Rank
    227,669
About

ONCOMEDX INC has a total of 45 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets biotechnology, machines and pharmaceuticals are CELLAY INC, LINGVITAE AS and FRESHGENE INC.

Patent filings per year

Chart showing ONCOMEDX INCs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Kopreski Michael S 31
#2 Kopreski Michael 11
#3 Gocke Christopher D 11
#4 Kopreski Mike 2
#5 Michael S Kopreski 1
#6 Christopher D Gocke 1

Latest patents

Publication Filing date Title
US2010159464A1 Method for Detection of DNA Methyltransferase RNA in Plasma and Serum
US2009136942A1 Analysis of Extracellular RNA
US2008286784A1 Method for Detection of DNA Methyltransferase RNA in Plasma and Serum
US2009233276A1 Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions
US8043835B1 Methods for detecting and monitoring cancer using extracellular RNA
US2006228729A1 Comparative analysis of extracellular RNA species
AU2002362055A1 Detection of matrix metalloproteinase rna in plasma and serum
CA2467629A1 Methods for evaluating drug-resistance gene expression in the cancer patient
AU2002327308A1 Methods for evaluating pathologic conditions using extracellular rna
AU2002345854A1 Methods for detecting and monitoring cox-2 rna in plasma and serum
US6759217B2 Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US7767422B2 Detection of 5T4 RNA in plasma and serum
EP1354060A2 5t4 rna in plasma and serum as a marker for neoplastic disease
US6607898B1 Method for detection of hTR and hTERT telomerase-associated RNA in plasma or serum
US6794135B1 Method for detection of 5T4 RNA in plasma or serum